Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04449315 · ClinicalTrials.gov registry record · NA
Outpatient Oncology Aromatherapy for Symptom Management
A NA study, sponsored by Central DuPage Hospital.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04449315: Completed NA study, sponsored by Central DuPage Hospital.
NCT04449315 is a NA study that has completed, run by Central DuPage Hospital. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04449315, a NA study, has completed, sponsored by Central DuPage Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine whether using aromatherapy during chemotherapy infusion treatments in the outpatient Oncology setting promote relief of nausea and anxiety. The objectives of this study are: 1. To promote relief of nausea using peppermint aromatherapy oil in an outpatient oncology setting. 2. To promote relief of anxiety using lavender aromatherapy oil in an outpatient oncology setting.
Primary Outcome
After the patients' infusion they will be asked questions from this form
Interventions
- OTHER Young Living Lavender Essential Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-10-10 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
What the finished NCT04449315 record still lists
NCT04449315 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Young Living Lavender Essential Oil is the first listed.
NCT04449315 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04449315 about?
NCT04449315 is a clinical study titled "Outpatient Oncology Aromatherapy for Symptom Management". The purpose of this research study is to determine whether using aromatherapy during chemotherapy infusion treatments in the outpatient Oncology setting promote relief of nausea and anxiety. The objectives of this study are: 1. To promote relief of nausea using peppermint aromatherapy oil in an out...
What is the current status of trial NCT04449315?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-10-10. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT04449315?
The interventions under investigation include: Young Living Lavender Essential Oil (OTHER).
Who is sponsoring clinical trial NCT04449315?
This trial is sponsored by Central DuPage Hospital, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04449315's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI